<DOC>
	<DOCNO>NCT00526383</DOCNO>
	<brief_summary>Since antidepressant antipsychotic common receptorial mechanism action ( H1 antagonism , 5HT2 antagonism ) , impact antidepressant term metabolic syndrome matter concern . The main objective study assess differential impact antidepressant term weight gain metabolic syndrome .</brief_summary>
	<brief_title>Do Antidepressants Induce Metabolic Syndromes METADAP Study</brief_title>
	<detailed_description>Since antidepressant antipsychotic common receptorial mechanism action ( H1 antagonism , 5HT2 antagonism ) , impact antidepressant term metabolic syndrome matter concern . The main objective study assess differential impact antidepressant term weight gain metabolic syndrome . Prospective 6-month naturalistic cohort study , compare 4 class antidepressant ( SSRIs , SNRIs , TCAs others ) control group ( ECT r-TMS ) , 600 patient major depressive disorder require begin either antidepressant ECT/r-TMS treatment .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Antidepressive Agents , Tricyclic</mesh_term>
	<criteria>Age : 1870 Current major depressive episode ( Major depressive disorder ) base MINI interview HAMD &gt; 18 Requiring either antidepressant treatment , either ECT rTMS ( assessed clinician ) Signed informed consent Bipolar disorder ( DSMIV ) , Psychotic disorder ( DSMIV ) , Substance abuse dependence ( DSMIV ) Normothymic treatment Antipsychotic treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Major depressive disorder</keyword>
	<keyword>Antidepressants</keyword>
	<keyword>Weight gain</keyword>
	<keyword>Metabolic syndrome</keyword>
</DOC>